The US Intravenous Immunoglobulin Market is on a trajectory of significant growth, projected to reach a market size of approximately USD 4,050 million by 2035. This reflects a commendable compound annual growth rate (CAGR) of 3.75% from 2024, when the market size is expected to start at USD 2,700 million. A combination of increasing demand for immunotherapy, especially in the treatment of...